Antibodies recognizing MAGEA4, THY1, IGF2BP1, VIM, CTNNB1, and FN1 proteins, whose expression differed significantly in BC cells vs. HCV29 cells, were used to confirm the results of previous analyses and to assess protein distributions. This evidence concerns the gene FN1 and breast cancer.